COVID-19：ZOLL增加了呼吸器的产量：25倍，每月10,000台
2020年3月25日
旭化成：ZOLL
旭化成将增加其子公司ZOLL Medical Corp的产量，以应对由于COVID-19感染扩散而引起的呼吸器需求。
我们将通知您，我们已决定将产量提高到10,000个/月，大约是当前数量的25倍。
新闻稿|旭化成株式会社
https://www.asahi-kasei.co.jp/asahi/jp/news/2019/ze200325.html
ZOLL Executing a Plan to Build 10,000 Ventilators/Month in Response to COVID-19 Pandemic
March 23, 2020 —
CHELMSFORD, MASS. —
ZOLL® Medical Corporation,
an Asahi Kasei Group company that manufactures medical devices and related software solutions, is taking aggressive steps to increase manufacturing capacity to 10,000 ventilators per month in response to the COVID-19 pandemic.
This represents almost a 25-fold expansion from recent production volumes.
The company has reached out to its supply base, most of which is in the United States, to enlist their support in meeting this demand.
ZOLL Medical
Asahi Kasei Unit to Increase Ventilator Production
Tokyo, March 25 (Jiji Press)–
Japanese chemical maker Asahi Kasei Corp. <3407> said Wednesday that a U.S. unit will increase ventilator production in response to rising demand amid the COVID-19 pandemic.
The Massachusetts-based unit,
Zoll Medical Corp.,
aims to increase production to 10,000 units per month, almost a 25-fold expansion from recent volumes.
JIJI PRESS